These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 22845716)
1. PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget's disease. Qian Y; Zhang N; Chen S; Chu S; Feng A; Liu H J Cutan Pathol; 2012 Nov; 39(11):1010-5. PubMed ID: 22845716 [TBL] [Abstract][Full Text] [Related]
2. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease. Chen SY; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu YT; Furue M Arch Dermatol Res; 2008 Apr; 300(4):195-201. PubMed ID: 18210145 [TBL] [Abstract][Full Text] [Related]
3. The expression of HER-2 in extramammary Paget's disease. Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949 [TBL] [Abstract][Full Text] [Related]
4. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease. Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144 [TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease. Liu H; Moroi Y; Yasumoto S; Kokuba H; Imafuku S; Koga T; Masuda T; Tu Y; Furue M; Urabe K Br J Dermatol; 2006 Sep; 155(3):586-91. PubMed ID: 16911286 [TBL] [Abstract][Full Text] [Related]
6. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease. Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K J Cutan Pathol; 2009 Apr; 36(4):402-8. PubMed ID: 19278424 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic progenitor kinase 1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase 1, and phosphomitogen-activated protein kinase kinase 4 are overexpressed in extramammary Paget disease. Qian Y; Takeuchi S; Dugu L; Tsuji G; Xie L; Nakahara T; Takahara M; Moroi Y; Tu YT; Furue M Am J Dermatopathol; 2011 Oct; 33(7):681-6. PubMed ID: 21915030 [TBL] [Abstract][Full Text] [Related]
8. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease. Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease. Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852 [TBL] [Abstract][Full Text] [Related]
10. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease. Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease. Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic mutations in extramammary Paget's disease and their clinical relevance. Kang Z; Xu F; Zhang QA; Wu Z; Zhang X; Xu J; Luo Y; Guan M Int J Cancer; 2013 Feb; 132(4):824-31. PubMed ID: 22821211 [TBL] [Abstract][Full Text] [Related]
14. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease. Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth. Shiomi T; Noguchi T; Nakayama H; Yoshida Y; Yamamoto O; Hayashi N; Ohara K J Eur Acad Dermatol Venereol; 2013 May; 27(5):589-92. PubMed ID: 22364152 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease. Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449 [TBL] [Abstract][Full Text] [Related]
17. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Tsutsumida A; Otsuka F; Yamazaki N Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223 [TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators in 35 patients with extramammary Paget's disease. Ito Y; Igawa S; Ohishi Y; Uehara J; Yamamoto AI; Iizuka H Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients. Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523 [TBL] [Abstract][Full Text] [Related]
20. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease. Aoyagi S; Akiyama M; Shimizu H J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]